Viral escape in cerebrospinal fluid - An achilles heel of HIV therapy?

Journal of Infectious Diseases

Volumn 202, Issue 12, 2010, Pages 1768-1769

  Clifford, David B ^a  

^a WASHINGTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CEREBROSPINAL FLUID ANALYSIS; COGNITION; EDITORIAL; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION CONTROL; PRIORITY JOURNAL; VIRUS REPLICATION;

ANTI-HIV AGENTS; BLOOD-BRAIN BARRIER; CEREBROSPINAL FLUID; HIV INFECTIONS; HIV-1; HUMANS; PLASMA; TREATMENT OUTCOME; VIRAL LOAD;

EID: 78650365308     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/657343     Document Type: Editorial

References (9)

1. Edén A, Dietmar F, Hagberg L, et al. HIV-1 viral escape in cerebrospinal fluid of subjects on suppressive antiretroviral treatment. J Infect Dis 2010; 202(12):1819-1825 (in this issue).
2. Ellis RJ, Hsia K, Spector SA, et al. Cerebrospinal fluid human immunodeficiency virus type 1 RNA levels are elevated in neurocognitively impaired individuals with acquired immunodeficiency syndrome. Ann Neurol 1997; 42: 679-688.
3. Canestri A, Lescure FX, Jaureguiberry S, et al. Discordance between cerebral spinal fluid and plasma HIV replication in patients with neurological symptoms who are receiving suppressive antiretroviral therapy. Clin l Infect s Dis 2010; 50:773-778.
4. Letendre S, Marquie-Beck J, Capparelli E, et al. Validation of the CNS penetration-effectiveness rank for quantifying antiretroviral penetration into the central nervous system. Arch Neurol 2008; 65(1):65-70.
5. Kelder W, McArthur JC, Nance-Sproson T, McClernon D, Griffin DE. b-chemokines MCP-1 and RANTES are selectively increased in cerebrospinal fluid of patients with human immunodeficiency virus-associated dementia. Ann Neurol 1998; 44:831-835.
6. Wesselingh SL, Power C, Glass JD, et al. Intracerebral cytokine messenger RNA expression in acquired immunodeficiency syndrome dementia. Ann Neurol 1993; 33:576-582.
7. Wesselingh SL, Glass J, McArthur JC, Griffin JW, Griffin DE. Cytokine dysregulation in HIVassociated neurological disease. Adv Neuroimmunol 1994; 4:199-206.
8. Simioni S, Cavassini M, Annoni JM, et al. Cognitive dysfunction in HIV patients despite longstanding suppression of viremia. AIDS 2010; 24:1243-1250.
9. Strategies for Management of Antiretroviral Therapy (SMART) Study Group. CD4+ countguided interruption of antiretroviral treatment. N Engl J Med 2006; 355(22):2283-2296.